Organ damage in patients treated with belimumab versus standard of care: a propensity score-matched comparative analysis

OBJECTIVES: The study (206347) compared organ damage progression in patients with systemic lupus erythematosus (SLE) who received belimumab in the BLISS long-term extension (LTE) study with propensity score (PS)-matched patients treated with standard of care (SoC) from the Toronto Lupus Cohort (TLC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Urowitz, Murray B, Ohsfeldt, Robert L, Wielage, Ronald C, Kelton, Kari A, Asukai, Yumi, Ramachandran, Sulabha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Systemic Lupus Erythematosus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390027/
https://www.ncbi.nlm.nih.gov/pubmed/30610066
http://dx.doi.org/10.1136/annrheumdis-2018-214043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390027/
https://www.ncbi.nlm.nih.gov/pubmed/30610066
http://dx.doi.org/10.1136/annrheumdis-2018-214043

Ejemplares similares